Delivery Order SPE2DB20D2104-SPE2DB23FQ73A
Award Date 10/14/22
Potential Completion Date 10/17/22
Potential Value $10K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $32,477.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. This is a firm-fixed price delivery order contract with a completion date of May 1, 2024. The contract was awarded on April 30, 2024, and does not have a set-aside designation, indicating it was awarded through full and open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $10,799.98, is a delivery order for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 15, 2024 and is a firm fixed-price contract type. This award is not associated with a set-aside designation,...
- This federal contract award, valued at $20,944.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The award has an ultimate completion date of April 24, 2023 and is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $14,248.83, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of November 8, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Delivery Order, valued at $3,353.77, is for STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. The contract has an ultimate completion date of January 29, 2024....
- This federal contract award, valued at $16,915.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Stelara 90 mg/ml syringes, a specialty pharmaceutical product, with a completion date of February 13, 2024. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and...
- This federal contract award, valued at $48,403.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Stelara 90 mg/ml syringes, a specialty medication. This is a firm fixed-price delivery order contract with a period of performance ending on January 31, 2024. The contract was awarded on an unrestricted, full and open competition basis with no set-aside designation. Amerisourcebergen Drug Corp is a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $11,121.88, is for the delivery of Stelara 45 mg/0.5 ml syringes, a specialty medication used for various medical conditions. The contract has an ultimate completion date of May 2, 2023 and is a firm fixed-price delivery order. The contract is not designated as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $12,568.40, is for the delivery of STELARA 90 MG/ML SYRINGE/ML medication and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2023. This contract does not have a set-aside designation, indicating it was awarded through full and open competition....
- This contract award, with a potential value of $5,322.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for STELARA 45 MG/0.5 ML syringes, a specialty pharmaceutical product, with an ultimate completion date of May 1, 2024. The contract was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...